If a drug can improve an individual's performance, and does not create side-effects, would it be such a bad thing? Miracle pills are discussed by Dr Bennett Foddy, Deputy Director, Institute for Science and Ethics, Oxford Martin School; Dr Hilary Leevers, Head of Education and Learning, Wellcome Trust; Dr Anders Sandberg, James Martin Fellow, Oxford Martin Programme on the Impacts of Future Technology; Dr James Wilson, Lecturer in Philosophy and Health, University College London. This event was part of the Next Big Thing seminar series held in partnership with Nesta and Policy Exchange.
Next big thing: The Miracle Pill - Panel discussion
01 May 2013